27 Dec, 10:34 - Indian

SENSEX 79029.25 (0.71)

Nifty 50 23927.599609375 (0.75)

Nifty Bank 51580.80078125 (0.80)

Nifty IT 43741.8984375 (0.18)

Nifty Midcap 100 57216.25 (0.16)

Nifty Next 50 69305.203125 (0.20)

Nifty Pharma 22881.349609375 (0.74)

Nifty Smallcap 100 18733.150390625 (0.02)

27 Dec, 10:34 - Global

NIKKEI 225 40319.34 (1.90)

HANG SENG 20158.6 (0.30)

S&P 6097 (-0.17)

Login/Signup
LOGIN HERE
Cancel

PVP Ventures Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 517556 | NSE Symbol : PVP | ISIN : INE362A01016 | Industry : Realty |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
28-Nov-2024 28-Nov-2024 Acquisitions Acquisition of BIOHYGEA GLOBAL PRIVATE LIMITED
01-Nov-2024 12-Nov-2024 Quarterly Results PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve quarterly results ending Sep 30 2024 alongwith the limited review reports. Financial results for quarter ending Sep 30, 2024. (As Per Bse Announcement Dated on 12.11.2024)
03-Sep-2024 03-Sep-2024 AGM Outcome of circular resolutions
06-Aug-2024 12-Aug-2024 Quarterly Results PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve The Board meeting is scheduled to be held on August 12 2024 for approving the quarterly results of the Company for the period ended June 30 2024 and other considering other corporate matters. The Board meeting is scheduled to be held on August 12 2024 for approving the quarterly results of the Company for the period ended June 30 2024 and other considering other corporate matters. Board meeting outcome (As Per Bse Announcement Dated on 12.08.2024)
17-May-2024 28-May-2024 Accounts PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (LODR) 2015 the meeting of the Board of Directors of the Company will be held on Tuesday May 28 2024 through Video conference to approve and consider the Audited Financial Results (Standalone & Consolidated) of the Company with Audit Report for the quarter & year ended March 31 2024. The trading window for dealing in the securities of the Company for the insiders was closed on April 01 2024 and will be opened 48 after the declaration of results. Outcome of Board Meeting held today i.e 28-05-2024 (As per BSE Announcement Dated on 28/05/2024) The Board of Directors of the Company at its meeting held on 28th May 2024 has appointed Mr. D Mahesh, Member of ICSI. as the Company Secretary & Compliance Officer of the Company w.e.f May 28, 2024. (As Per BSE Announcement Dated on 29.05.2024)
02-Feb-2024 13-Feb-2024 Quarterly Results PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (LODR) Reg 2015 the Board Meeting of the Board of Directors of the Company will be held on Monday February 12 2024 through Video Conference to approve and consider the Unaudited Financial Results (Standalone & Consolidated of the Company with Limited Review Report for the quarter ended December 31 2023. The trading window for dealing in the securities of the Company for the insiders was closed on January 01 2024 and will be opened after 48 hours from the declaration of results. PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve With reference to the intimation dated February 02, 2024, regarding Board Meeting to be held on Monday, February 12, 2024, we hereby intimate the Stock Exchange as per the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015, that the said Meeting of the Board of Directors of the Company is rescheduled on Tuesday, February 13, 2024, to consider and approve the Unaudited Financial Results (Standalone & Consolidated) with limited review report for the quarter ended December 31, 2023. Kindly take the above information on record. (As per BSE Announcement Dated on 09/02/2024) Pursuant to Reg 30, 33 of SEBI Listing Regulation 2015, we wish to inform that the board in their meeting held on 13th Feb, 2023 have approved the unaudited financial results both standalone & consolidated for the quarter ended Dec 31, 2023 along wiith limited review report. The Board of Directors in their meeting held on today i.e 13th Feb 2024 has considered and approved the request letter received from Mrs Sai Padma Potluri belonging to Promoter and Promoter Group, reclassifying from Promoter/Promoter Group to 'Public Category. (As Per BSE Announcement dated on 13.02.2024)
30-Oct-2023 08-Nov-2023 Quarterly Results PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve The Unaudited financial results (Standalone & Consolidated) of the Company with Limited Review Report for the quarter ended September 30 2023. Pursuant to Regulation 30 & 33 the board of directors at their meeting held on 8th Nov, 2023 have approved the unaudited financial results for quarter ended Sep 30,2023 along with limited review report. Pursuant to Regulation of 30 and 33 other applicable provisions of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that, the Board of Directors of the Company at their meeting held on Wednesday, November 08, 2023 have inter-alia: 1) Approved the Un-audited financial results (Standalone & Consolidated) for the Second (2) quarter/ half year ended September 30, 2023 along with Limited Review Report from the Statutory Auditor of the Company. 2) Resignation of Company Secretary, Ms. Derrin Ann George w.e.f 08 Nov 2023, on account of re-structuring of the group companies. Pursuant to Reg 30 of SEBI Listing Regulations this is to inform you that Ms. Derrin Ann George, company secretary has resigned w.e.f 8th Nov, 2023 on account of restructuring of the group companies. (As Per BSE Announcement Dated on 08/11/2023)
21-Aug-2023 24-Aug-2023 Preferential Issue PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015 we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Thursday August 24 2023 inter alia to consider preferential issue subject to shareholders approval by way of postal ballot. Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the Board at its meeting held today i.e. 24th August, 2023 inter-alia has approved the following matters: a. Acquisition of 100% stake of Humain Healthtech Pvt ltd b. Issue of 1,29,00,000 equity shares of the Company on preferential basis for consideration other than cash. c. Sale of PVP Media Ventures Pvt Ltd, wholly owned subsidiary of the company to PV Potluri Ventures Pvt Limited an entity belonging to the Promoter group. d. Sale of PVP Global Ventures Pvt Ltd, wholly owned subsidiary of the company to PV Potluri Ventures Pvt Limited an entity belonging to the Promoter group. e.Sale of 81% stake in New Cyberabad City Projects Pvt Ltd, material subsidiary of the company to Picturehouse Media Limited. f. Approval of Notice for Postal Ballot Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that, the Board at its meeting held today i.e 24th August 2023 inter-alia has approved the issue of 1,29,00,000 equity shares of the Company on Preferential basis for consideration other than cash. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular on Continuous Disclosures Requirements (SEBI Circular SEBI/HO/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023), concerning the issue of equity shares on a Preferential basis are enclosed. (As Per BSE Announcement dated on 24.08.2023)
16-Aug-2023 16-Aug-2023 Change in Directors Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the Board at its meeting held today on i.e. 16th August, 2023 has approved the appointment of Mr. Gautam Shahi (DIN:10236790) as an Additional Director in the category of Independent Director of the Company for a term of five (5) years with effect from 16th August, 2023 subject to the approval of shareholders. The requisite disclosure as required as per the requirement of Regulation 30 read with clause 7 of Part A of Schedule III of the Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 enclosed herewith as 'Annexure-1'.
27-Jul-2023 02-Aug-2023 Quarterly Results PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015 we wish to inform you that a Meeting of the Board of Directors of the Company will be held on Wednesday August 02 2023 through Video Conference to approve and consider the following; 1. The Unaudited financial results (Standalone & Consolidated) of the Company with Limited Review Report for the quarter ended June 30 2023. The trading window for dealing in the securities of the Company for the insiders was closed on Monday June 20 2023 and will be opened after 48 hours from the declaration of results. Pursuant to Regulation of 30, 33, and other applicable provisions of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that, the Board of Directors of the Company at their meeting held on August 02, 2023 have inter-alia: 1) Approved the Un-audited financial results (Standalone & Consolidated) for the First (1) quarter ended June 30, 2023 along with Limited Review Report from the Statutory Auditor. 2) Approved the notice convening the 32nd Annual General Meeting of the Company to be held on Friday, September 01,2023 3) Approved the Directors Reports with Annexures for the 32nd Annual General Meeting. 4) Approved the closure of the Register of Members and Transfer book from August 28, 2023 to September 01, 2023 (Both the days inclusive) for the purpose of Annual General Meeting of the Company. Approved the Unaudited Financial Results for Quarter ended June 30,2023 along with limited review report from the statutory auditors (As Per BSE Announcement Dated on 02.08.2023)
04-Jul-2023 04-Jul-2023 Change in Directors We would like to inform you that the Board at its meeting held today on i.e. 04th July 2023 on the recommendation of the Nomination Remuneration Committee has approved the appointment of Mr Arjun Ananth (DIN:01207540) as the Whole Time Director to the Board of Directors, in the designation of Chief Executive Officer ('CEO') of the Company subject to the approval of the shareholders as may be applicable. The requisite disclosure as required as per the requirement of Regulation 30 read with clause 7 of Part A of Schedule III of the Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, enclosed herewith as 'Annexure-1'. Pursuant to Regulation 30 and other applicable provisions of the SEBI (LODR, 2015) We would like to inform you that, the Board at its meeting held today i.e 04th July 2023, on the recommendation of the Nomination and Remuneration Committee has approved the appointment of Mr Arjun Ananth (DIN: 01207540) as the Whole Time Director to the Board of Directors, in the designation of Chief Executive Officer ('CEO') of the Company subject to the approval of the shareholders as may be applicable. The requisite disclosure as required under the requirement of Regulation 30 read with Clause 7 of Part A of Schedule III of the Listing Regulations, read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9,2015 enclosed as Annexure -1.
19-Jun-2023 22-Jun-2023 Preferential Issue PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/06/2023 inter alia to consider and approve We would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on 22nd June 2023 inter-alia to consider the issue of equity shares of the company by way of preferential issue for the purpose of acquisition of a company engaged in healthcare business for consideration other than cash for which issuance and allotment of equity shares shall be in accordance with applicable laws and shall be subject to such regulatory approvals as may be required including shareholders approval. The Board Meeting to be held on 22/06/2023 Stands Cancelled. (As per BSE Announcement Dated on 21/06/2023)
12-May-2023 23-May-2023 Accounts PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015 we wish to inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 23 2023 inter alia to consider and approve the Audited financial results (Standalone & Consolidated) of the Company with Audited Report for the quarter and year ended March 31 2023. As notified by the Company vide letter dated March 31 2023 pursuant to the Companys code to regulate monitor and report trading by Insiders the Trading Window for dealing in the securities of the Company has been closed for all the Designated Persons and their relatives from April 1 2023 and till the expiry of 48 hours from the date the said financial results are made public. The Board meeting held on May 23, 2023 have inter-alia approved the following: 1) Pursuant to Reg 30 and 33 of SEBI (LODR) Reg, 2015, we forward herewith the Audited Financial Results (Consolidated and Standalone) along with the Audit Reports, for the FY ended Mar 31, 2023. Reg (33)(3)(d) of SEBI LODR Statement on Impact of Audit Qualifications for the FY ended Mar 31, 2023 on Standalone and Consolidated Financial Statement is attached. 2) Approved the appointment of Mr. M Kumar, ACS 32149 as the Company Secretary & Compliance officer of the company. Ms. Derrin Ann George, has been re-designated as Deputy Company Secretary. 3) Approved appointment of Dr. Chandra Sekhar Rajanala, PCS as Secretarial Auditor for the FY Mar 2023. 4) Approved the Employee Stock Option Plan 2023, subject to the approval of the Shareholders and regulatory authorities (if any). The Board of Directors did not take up the agenda items deferred from the previous board meeting held on 16 May 2023. (As Per BSE Announcement Dated on 23/05/2023)
11-May-2023 16-May-2023 Preferential Issue PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 inter alia to consider and approve Pursuant to Regulation 29(1) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015 we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 16 2023 inter alia to consider preferential issue for the purpose of acquisition of a company engaged in Healthcare business for consideration other than cash and ESOP scheme. Employees Stock Option Plan(Cancelled) (Cancelled)& Preferential Issue of shares(Cancelled) (As Per BSE Bulletin Dated on 16.05.2023) Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at its meeting held today i.e. 16th May 2023 deferred considering the preferential issue for consideration other than cash to acquire a company engaged in Healthcare business, and ESOP scheme to the board meeting scheduled to be held on 23rd May 2023. The Board meeting commenced at 10.45 A.M and concluded at 4.45 P.M Please take the same on record. (As Per BSE Announcement Dated on 16.05.2023)
21-Apr-2023 28-Apr-2023 Conversion PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that a meeting of the Board of Directors of the Company will be held on Friday April 28 2023 inter-alia to consider and approve conversion of 5000 14.5% Fully Convertible Debentures into Equity Shares of the Company. We request you to kindly take the same on record. PVP VENTURES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 ,inter alia, to consider and approve In furtherance to intimation to stock exchange dated 21-04-2023, we would like to inform that, the meeting of the Board of Directors of the Company scheduled to be held on 28th April, 2023, inter-alia, to consider the issue of equity shares of the company by way of preferential issue for the purpose of acquisition of a company engaged in healthcare business for consideration other than cash, for which issuance and allotment of equity shares shall be in accordance with applicable laws and shall be subject to such regulatory approvals, as may be required, including shareholders' approval. (As per BSE Announcement Dated on 25/04/2023) Pursuant to Reg30 and other applicable provisions of the SEBI (LODR) Regulations, 2015, we would like to inform that the Board at its meeting held today i.e. 28th April, 2023 inter-alia has considered and approved the allotment of 24,50,980 fully paid-up Equity Shares of Rs.10/- each of the Company pursuant to the conversion of 5000, 14.5% Fully Convertible Debentures, having face value of Rs.100,000/- each at a conversion price of Rs.204/- per share pursuant to the Scheme of Amalgamation sanctioned by the Hon'ble High Court of Madras on April 25, 2008. In furtherance to the prior intimation of the board meeting given on 25th April, 2023, the board of directors deferred the discussion on preferential issue for proposed acquisition of company engaged in healthcare business. (As Per BSE Announcement dated on 28.04.2023) Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the Board at its meeting held today i.e. 28th April, 2023 inter-alia has considered and approved the allotment of 24,50,980 fully paid-up Equity Shares of Rs.10/- each of the Company pursuant to the conversion of 5000, 14.5% Fully Convertible Debentures, having face value of Rs.100,000/- each at a conversion price of Rs.204/- per share pursuant to the Scheme of Amalgamation sanctioned by the Hon'ble High Court of Madras on April 25, 2008. In furtherance to the prior intimation of the board meeting given on 25th April, 2023, the board of directors deferred the discussion on preferential issue for proposed acquisition of company engaged in healthcare business. The Board meeting commenced at 10.30 A.M and concluded at 3.15 P.M We request you to kindly take the same on record. (As Per BSE Announcement Dated on 02.05.2023)
1 2 3